Abri Ventures 2, LLC - 18 May 2022 Form 3 Insider Report for Abri SPAC 2, Inc.

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
18 May 2022, 20:30:39 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jeffrey Tirman, Authorized Person of Abri Ventures 2 LLC

Key filing fact

Abri Ventures 2, LLC filed Form 3 for Abri SPAC 2, Inc. on 18 May 2022.

Key facts

  • This page summarizes Abri Ventures 2, LLC's Form 3 filing for Abri SPAC 2, Inc..
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 18 May 2022, 20:30.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ASPPU holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,875,000
Date
18 May 2022
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

As described in the issuer's registration statement on Form S-1 (File No. 333-264322) under the heading "Description of Securities."

Footnote F2

These shares represent 2,875,000 shares of common stock held by Abri Ventures 2, LLC (the "Sponsor"), acquired pursuant to a private placement by and between the Sponsor and the registrant, of which up to 375,000 shares are subject to forfeiture in the event the underwriters of the initial public offering of the registrant's securities do not exercise in full their over-allotment option as described in the registrant's registration statement.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .